D
DSGN
Design Therapeutics, Inc.
11.92
+0.43+3.74%Opening10:12 10/09 EDT
OPEN/PREV CLOSE11.47/11.49
TODAY RANGE11.40-11.92
VOL26.59K
MARKET CAP745.97M
52 WEEK RANGE5.28-17.25
AVG VOL (3M)604.15K
% TURNOVER0.04%
TURNOVER--
P/E (TTM)-10.0974
% RANGE4.53%
EPS(TTM)-1.1805
P/E(FORWARD)-8.8296
P/B3.695
BVPS3.226
DIVIDEND--
P/S1,804.76
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP487.65M
SHARES OUTSTANDING62.58M
NEXT EARNINGS11/03-11/09
FREE FLOAT40.91M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·3d ago
Oppenheimer's fall 2026 SMID-cap ideas include four Strong Buy stocks
Seeking Alpha·6d ago
Design Therapeutics a new overweight at Wells Fargo on Friedreich ataxia program
TipRanks·10/02 13:46
Nike downgraded, Airbnb upgraded: Wall Street’s top analyst calls
TipRanks·10/02 09:35
Design Therapeutics initiated with an Overweight at Wells Fargo
TipRanks·09/03 18:35
Design Therapeutics management to meet with Oppenheimer
Seeking Alpha·09/02 16:25
Monthly top ideas from Oppenheimer include MA, MRVL, CMG, and more
Benzinga·08/28 12:02
Marvell Technology, PayPal, Rubrik And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
TipRanks·08/06 01:47
RBC Capital Sticks to Their Buy Rating for Design Therapeutics (DSGN)
TipRanks·08/03 12:22
Design Therapeutics reports Q2 EPS (32c), consensus (34c)
Seeking Alpha·08/03 12:04
Design Therapeutics GAAP EPS of -$0.32 beats by $0.02
Benzinga·08/03 12:04
Design Therapeutics Q2 EPS $(0.32) Beats $(0.34) Estimate
Same Industry
Name/Symbol
Change%
Price